Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

48.26 -0.06 (-0.12%)

Streaming Delayed Price Updated: 12:50 PM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	586,771
Open	48.34
Bid (Size)	48.22 (2,400)
Ask (Size)	48.26 (1,300)
Prev. Close	48.32
Today's Range	48.17 - 48.49
52wk Range	44.62 - 60.12
Shares Outstanding	1,250,690,553
Dividend Yield	4.58%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine

Today 10:23 EST

As of today, December 24, 2025, the global pharmaceutical landscape is witnessing a profound consolidation of power within specialty medicine and immunology. Sanofi (NASDAQ: SNY; Euronext: SAN), the...

Via PredictStreet

Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition

Today 10:21 EST

Introduction On December 24, 2025, the biotechnology sector received its most significant holiday gift in years. Sanofi (NASDAQ: SNY; Euronext: SAN) announced a definitive agreement to acquire Dynavax...

Via PredictStreet

Performance

YTD	+0.1%	+0.1%
1 Month	-1.8%	-1.8%
3 Month	+2.9%	+2.9%
6 Month	-0.3%	-0.3%
1 Year	-0.3%	-0.3%

More News

Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring

Today 10:12 EST

Via MarketMinute

Why Did Dynavax Stock Surge 38% In Premarket Today? ↗

Today 5:56 EST

Via Stocktwits

Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗

December 23, 2025

Via Stocktwits

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

December 23, 2025

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally

December 22, 2025

Via MarketMinute

Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗

December 19, 2025

Via Stocktwits

Is Alnylam Pharmaceuticals a Millionaire Maker? ↗

December 07, 2025

Via The Motley Fool

Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗

December 01, 2025

Via Investor's Business Daily

Should You Buy This Biotech Stock That Just Gained 5% in 1 Day? ↗

November 30, 2025

Via The Motley Fool

Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation ↗

November 26, 2025

Via Investor's Business Daily

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

November 25, 2025

From Regeneron Pharmaceuticals, Inc.

Via GlobeNewswire

AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines

November 14, 2025

Via TokenRing AI

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

Via MarketMinute

Why Roche Holding Stock Popped Today ↗

November 10, 2025

Via The Motley Fool

TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results ↗

November 10, 2025

Via Investor's Business Daily

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60% ↗

November 08, 2025

Via Investor's Business Daily

AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns

November 05, 2025

Via TokenRing AI

AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential

November 04, 2025

Via TokenRing AI

AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio

November 01, 2025

Via TokenRing AI

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness ↗

October 28, 2025

Via Benzinga

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey

October 27, 2025

From Medidata Solutions, Inc.

Via GlobeNewswire

Sanofi Soars as Dupixent Sales Near €5 Billion Amidst Intensifying Trump Drug Pricing Negotiations

October 24, 2025

Via MarketMinute

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark ↗

October 24, 2025

Via Benzinga

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?

Yes, Sanofi - American Depositary Shares is publicly traded.

What exchange does Sanofi - American Depositary Shares trade on?

Sanofi - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Sanofi - American Depositary Shares?

The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market

What is the current price of Sanofi - American Depositary Shares?

The current price of Sanofi - American Depositary Shares is 48.26

When was Sanofi - American Depositary Shares last traded?

The last trade of Sanofi - American Depositary Shares was at 12/24/25 12:50 PM ET

What is the market capitalization of Sanofi - American Depositary Shares?

The market capitalization of Sanofi - American Depositary Shares is 60.36B

How many shares of Sanofi - American Depositary Shares are outstanding?

Sanofi - American Depositary Shares has 60B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.